Fundz
New|Fundz now works inside Claude2 min

Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.

Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Arboretum LifeSciences raises $30M in Series A funding to enhance scientific infrastructure and accelerate genetic testing adoption.

PRIVATEOct 07, 2026

Amount Raised

$30 Million

Round Type

Series A

CambridgeBiotechnologyHealth CareMedicalGeneticsHealth Diagnostics

Investors

AmgenHims & Hers.406 VenturesGVF Prime

Description

Arboretum LifeSciences, based in Cambridge, MA, raised $30M in Series A financing. The funding will be used to build scientific and operational infrastructure, expand product development, and scale its molecular research network. Backers included F-Prime, GV, and .406 Ventures. The company focuses on integrating AI with genetic testing for common diseases.

Company Information

Company

Arboretum LifeSciences

Location

Cambridge, Massachusetts, United States

About

Arboretum LifeSciences is a molecular information company based in Cambridge, MA. They integrate AI and genetic testing to apply genomic medicine to common diseases. Their platform offers clinical genetic testing and a collaborative research network to aid health systems and biopharma partners. The company focuses on identifying at-risk patients and designing genomically stratified clinical trials.

Fundz sees it the moment Arboretum LifeSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Arboretum LifeSciences's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Arboretum LifeSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.